mup

Imupedone (LF 1695) is a synthetic immunomodulator that modulates T lymphocytes and macrophages, induces T-cell differentiation of bone marrow precursor cells, and increases the proliferative response of lymphocytes to mitogens, antigens, and allogeneic cells.13483-84-5

Mupirocin (BRL-4910A) is a RNA synthetase inhibitor antibacterial. It has shown excellent activity against gram-positive staphylococci and streptococci.

Mupirocin calcium hydrate is an antibiotic produced by Pseudomonas fluorescens, showed a high level of activity against staphylococci and streptococci and against certain gram-negative bacteria

DiFMUP (6,8-Difluoro-4-methylumbelliferyl phosphate) inhibits protein tyrosine phosphatases (PTPs) and can be used to assay threonine phosphatase activity.

KMUP-3 is an enhancer of cGMP activity, and acts as an aortic smooth muscle relaxant.

Kmup-4 is an enhancer of cGMP activity and an aortic smooth muscle relaxant.

DMUP, a potent inhibitor of the CD47-SIRPα axis, effectively induces apoptosis and enhances macrophage phagocytosis in A549 cells while reducing the expression of CD47 and SIRPα proteins, exhibiting significant antitumor activity.

Mupirocin calcium (BRL-4910A, Pseudomonic acid), an orally active antibiotic derived from Pseudomonas fluorescens, exerts its antimicrobial effects by reversibly inhibiting isoleucyl-transfer RNA. This action impedes bacterial protein and RNA synthesis, demonstrating its effectiveness [1] [2].

Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.

Mupinensisone is a natural product of Celastrus, Celastraceae. The catalog number is TN5951 and the CAS number is 152253-67-3. Mupinensisone can be used as a reference standard.

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.